Thursday, 9 September 2010
K2 Pedia! | Rexahn Pharmaceuticals Submits Serdaxin Phase IIb Protocol To FDA For Major Depressive Disorder (MDD) | Major, Fda, Depressive, Disorder, Clinical, Protocol, Mdd, Pharmaceuticals, Iib, Serdaxin, Phase, Rexahn, Food, Submitted, Cns, Oncology, Therapeutics, Announced, Study, Class http://www.k2pedia.com/depressions/82017-rexahn-pharmaceuticals-submits-serdaxin-phase-iib-protocol-to-fda-for-major-depressive-disorder-mdd-
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment